期刊文献+

重组人B型利钠肽静脉注射对急性失代偿性心力衰竭合并急性肾损伤患者心、肾功能的影响 被引量:9

Effect of recombinant human B-type natriuretic peptide on heart and renal function in acute decompensated heart failure patients with acute kidney injury
暂未订购
导出
摘要 目的探讨静脉注射重组人B型利钠肽(rhBNP)对急性失代偿性心力衰竭(ADHF)合并急性肾损伤(AKI)患者心、肾功能的影响及预后。方法 40例符合ADHF合并AKI的患者纳入研究,在常规利尿剂应用无效的基础上,20例患者予利尿剂加量治疗(对照组),20例予rhBNP静脉注射治疗(治疗组)。观察两组治疗前后血肌酐(SCr)、估算的肾小球滤过率(eGFR)、血浆B型利钠肽(BNP)水平及左心室射血分数(LVEF)的变化。随访90d的死亡率、再住院率、再发心力衰竭及肾功能的变化。结果治疗组治疗后48h的SCr水平显著低于对照组(P<0.01);治疗后7d的eGFR和LVEF均显著高于对照组(P值分别<0.05、0.01),血浆BNP水平显著低于对照组(P<0.01);两组治疗后收缩压的差异无统计学意义(P>0.05)。随访90d,对照组再住院8例(40%),再发心力衰竭8例(40%),肾功能恢复12例(60%),死亡3例(15%);治疗组再住院4例(20%),再发心力衰竭2例(10%),肾功能恢复14例(70%),死亡1例(5%)。结论对ADHF合并AKI患者应用rhBNP静脉注射治疗较利尿剂加量治疗能更有效地改善患者的心、肾功能。 Objective To investigate the effect of intravenous injection of recombinant human B-type natriuretic peptide(rhBNP) on heart and renal function in the patients suffered from acute decompensated heart failure(ADHF) combined with acute kidney injury(AKI) and the prognosis.Methods Forty patients with ADHF combined with AKI were enrolled in this study.After invalidation of routine diuretics therapy,20 patients in control group were intravenously given additional diuretics,and 20 patients in rhBNP group were intravenously given rhBNP.Serum creatinine(SCr),estimated glomerular filtration rate(eGFR),serum B-type natriuretic peptide(BNP) and left ventricular ejection fraction(LVEF) were measured before and after treatment.Mortality,rehospitalization rate,recurrence of heart failure and renal function were followed up for 90 days.Results SCr in rhBNP group was significantly lower than that in control group 48 h after treatment(P0.01).eGFR and LVEF in rhBNP group was significantly higher than those in control group(P0.05,P0.01) and serum BNP level in rhBNP group were significantly lower than that in control group(P0.01) 7 d after treatment.Until day 90 of follow-up,3 patients(15%) died,8(40%) were rehospitalized,8(40%) had recurred heart failure and 12(60%) had restored renal fanction in control group;1(50%) died,4(20%) were rehospitalized,2(10%) had recurred heart failure and 14(70%) had restored renal fanction in rhBNP group.Conclusion Compared with additional diuretics therapy,intravenous rhBNP therapy may effectively improve the heart and renal function in the patients with ADHF combined with AKI.
出处 《上海医学》 CAS CSCD 北大核心 2011年第12期938-941,共4页 Shanghai Medical Journal
关键词 重组人脑利钠肽 利尿剂 急性失代偿性心力衰竭 急性肾损伤 心功能 肾功能 Recombinant B-type natriuretic peptide Diuretics Acute decompensated heart failure Acute renal injury Heart function Renal function
  • 相关文献

参考文献14

  • 1梅长林,张彤.急性肾损伤的诊断及治疗进展[J].上海医学,2009(3):177-179. 被引量:39
  • 2DE CASTRO F D, CHAVES P C, LEITE-MOREIRA A F. Cardiorenal syndrome and its pathophysiotogieal implications [J]. RevPort Cardiol, 2010, 29(10): 1535-1554.
  • 3KEATING G M, GOA K L. Nesiritide: a review of its use in aeute deeompensated heart failure[J]. Drugs, 2003, 63 (1) : 47-70.
  • 4OWAN T E, CHEN H H, FRANTZ R P, et al. The effects of nesiritide on renal function and diuretic responsiveness in acutely decompensated heart failure patients with renal dysfunction[J]. J Card Fail, 2008, 14(4): 267-275.
  • 5MILLER W L, KURIEN S, WARFIELD K T, et al. Lack of association between worsening renal function and mortality in heart failure patients treated with nesiritide[J]. Int J Cardiol, 2008, 126(2): 234-239.
  • 6ZHANG J, FU X, JUA X, et al. B-type natriuretic peptide for prevention of contrast-induced nephropathy in patients with heart failure undergoing primary percutaneous coronary intervention[J]. Acta Radiol, 2010, 51(6): 641-648.
  • 7ELKAYAM U, AKHTER M W, LIU M, et al. Assessment of renal hemodynamic effects of nesiritide in patients with heart failure using intravascular Doppler and quantitative angiography[J]. JACC Cardiovasc Imaging, 2008, 1 (6) : 765-771.
  • 8CHEN H H, CATALIOTTI A, SCHIRGER J A, et al. Local renal delivery of a natriuretie peptide a renal-enhancing strategy for B-type natriuretie peptide in overt experimental heart failure [ J ]. J Am Coll Cardiol, 2009, 53 ( 15 ) 1302-1308.
  • 9BRUNNER-LA ROCCA H P, KAYE D M, WOODS R L, et al. Effects ozf intravenous brain natriuretic peptide on regional sympathetic activity in patients with chronic heart failure as compared with healthy control subjects [J]. J Am Coll Cardiol, 2001, 37(5): 1221-1227.
  • 10JENSEN K T, CARSTENS J, PEDERSEN E B. Effect of BNP on renal hemodynamics, tubular function and vasoactive hormones in humans[J]. Am J Physiol, 1998, 274(1 Pt 2) F63-F72.

二级参考文献23

  • 1Kellum J A. Acute kidney injury. Crit Care Med, 2008, 36 (Suppl 4) : S141-S145.
  • 2Farley S J. Acute kidney injury/acute renal failure: standardizing nomenclature, definitions and staging. Nat Clin Pract Nephrol, 2007, 3:405.
  • 3Bellomo R, Roneo C, Kellum J A, et al. Acute renal failure- definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care, 2004, 8: R204-R212.
  • 4Mehta R L, Kellum J A, Shah S V, et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care, 2007, 11:R31.
  • 5Waikar S S, Bonventre J V. Biomarkers for the diagnosis of acute kidney injury. Curr Opin Nephrol Hypertens, 2007, 16: 557-564.
  • 6Vinsonneau C, Camus C, Combes A, et al. Continuous veno venous haemodiafiltration versus intermittent haemodialysis for acute renal failure in patients with multiple-organ dysfunction syndrome: a multicentre randomised trial. Lancet, 2006, 368: 379-385.
  • 7Pannu N, Klarenbach S, Wiebe N, et al. Renal replacement therapy in patients with acute renal failure: a systematic review. JAMA, 2008, 299: 793-805.
  • 8Kielstein J T, Kretschmer U, Ernst T, et al. Efficacy and cardiovascular tolerability of extended dialysis in critically ill patients: a randomized controlled study. Am J Kidney Dis, 2004, 43: 342-349.
  • 9Tolwani A J, Campbell R C, Stofan B S, et al. Standard versus high-dose CVVHDF for ICU-related acute renal failure. J Am Soc Nephrol, 2008, 19: 1233-1238.
  • 10Bagshaw S M, McAlister F A, Manns B J, et al. Acetylcysteine in the prevention of contrast-induced nephropathy: a case study of the pitfalls in the evolution of evidence. Arch Intern Med, 2006, 166: 161-166.

共引文献46

同被引文献112

引证文献9

二级引证文献70

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部